Allison JP - Search Results

1

The Next Decade of Immune Checkpoint Therapy.

Sharma P, Siddiqui BA, Anandhan S, Yadav SS, Subudhi SK, Gao J, Goswami S, Allison JP. Sharma P, et al. Among authors: allison jp. Cancer Discov. 2021 Apr;11(4):838-857. doi: 10.1158/2159-8290.CD-20-1680. Cancer Discov. 2021. PMID: 33811120 Review.

2

Immunotherapeutic strategies for high-risk bladder cancer.

Sharma P, Old LJ, Allison JP. Sharma P, et al. Among authors: allison jp. Semin Oncol. 2007 Apr;34(2):165-72. doi: 10.1053/j.seminoncol.2006.12.004. Semin Oncol. 2007. PMID: 17382800 Free PMC article. Review.

3

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.

Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA, Scardino PT, Sharma P, Allison JP. Zang X, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19458-63. doi: 10.1073/pnas.0709802104. Epub 2007 Nov 27. Proc Natl Acad Sci U S A. 2007. PMID: 18042703 Free PMC article.

4

Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.

Carthon BC, Wolchok JD, Yuan J, Kamat A, Ng Tang DS, Sun J, Ku G, Troncoso P, Logothetis CJ, Allison JP, Sharma P. Carthon BC, et al. Among authors: allison jp. Clin Cancer Res. 2010 May 15;16(10):2861-71. doi: 10.1158/1078-0432.CCR-10-0569. Epub 2010 May 11. Clin Cancer Res. 2010. PMID: 20460488 Free PMC article. Clinical Trial.

5

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps.

Sharma P, Wagner K, Wolchok JD, Allison JP. Sharma P, et al. Among authors: allison jp. Nat Rev Cancer. 2011 Oct 24;11(11):805-12. doi: 10.1038/nrc3153. Nat Rev Cancer. 2011. PMID: 22020206 Free PMC article. Review.

6

Retrospective. Lloyd J. Old (1933-2011).

Sharma P, Allison JP. Sharma P, et al. Among authors: allison jp. Science. 2012 Jan 6;335(6064):49. doi: 10.1126/science.1217940. Science. 2012. PMID: 22223799 No abstract available.

7

Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe".

Curran MA, Callahan MK, Subudhi SK, Allison JP. Curran MA, et al. Among authors: allison jp. Immunobiology. 2012 Jun;217(6):590-2. doi: 10.1016/j.imbio.2011.11.001. Epub 2011 Nov 17. Immunobiology. 2012. PMID: 22459268 No abstract available.

8

Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.

Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H, Scardino PT, Slovin S, Subudhi SK, Reuter VE, Savage C, Allison JP, Melamed J, Jäger E, Ritter G, Old LJ, Gnjatic S. Reis BS, et al. Among authors: allison jp. Clin Cancer Res. 2013 Nov 15;19(22):6112-25. doi: 10.1158/1078-0432.CCR-12-3580. Epub 2013 Sep 30. Clin Cancer Res. 2013. PMID: 24081977

9

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.

Zamarin D, Holmgaard RB, Subudhi SK, Park JS, Mansour M, Palese P, Merghoub T, Wolchok JD, Allison JP. Zamarin D, et al. Among authors: allison jp. Sci Transl Med. 2014 Mar 5;6(226):226ra32. doi: 10.1126/scitranslmed.3008095. Sci Transl Med. 2014. PMID: 24598590 Free PMC article.

10

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy.

Fan X, Quezada SA, Sepulveda MA, Sharma P, Allison JP. Fan X, et al. Among authors: allison jp. J Exp Med. 2014 Apr 7;211(4):715-25. doi: 10.1084/jem.20130590. Epub 2014 Mar 31. J Exp Med. 2014. PMID: 24687957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page